<乌鸦传媒>Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
<乌鸦传媒>T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
<乌鸦传媒>Subclasses of Steatotic Liver Disease Can Help Determine Prognosis Risk of liver decompensation increased progressively when alcohol intake came into play Jan 18, 2024
<乌鸦传媒>Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
<乌鸦传媒>T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
<乌鸦传媒>Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
<乌鸦传媒>Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
<乌鸦传媒>Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
<乌鸦传媒>Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
<乌鸦传媒>New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves News and commentary from the endocrinology world Dec 12, 2023
<乌鸦传媒>USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesity Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
<乌鸦传媒>Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
<乌鸦传媒>Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
<乌鸦传媒>Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
<乌鸦传媒>Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
<乌鸦传媒>Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<乌鸦传媒>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
<乌鸦传媒>Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<乌鸦传媒>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
<乌鸦传媒>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
<乌鸦传媒>Certain Factors Predict Weight Regain After Big Losses But even "regainers" still kept off most of the weight Oct 17, 2023
<乌鸦传媒>Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortality Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
<乌鸦传媒>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<乌鸦传媒>Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risks Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
<乌鸦传媒>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
<乌鸦传媒>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<乌鸦传媒>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<乌鸦传媒>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<乌鸦传媒>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<乌鸦传媒>Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
<乌鸦传媒>Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
<乌鸦传媒>Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
<乌鸦传媒>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<乌鸦传媒>Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx News and commentary from the endocrinology world Sep 05, 2023
<乌鸦传媒>Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use? News and commentary from the endocrinology world Aug 29, 2023
<乌鸦传媒>Testosterone Loss in Older Men: Factors Beyond Age in the Mix Several lifestyle, health factors associated with declining levels Aug 28, 2023
<乌鸦传媒>Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits News and commentary from the endocrinology world Aug 15, 2023
<乌鸦传媒>Trial Supports GLP-1 After Underwhelming Metabolic Surgery Helped more patients achieve clinically significant weight loss Jul 27, 2023
<乌鸦传媒>Yet Another Injectable Combo Achieves Near 15% Weight Loss in Trial But GI side effects higher than other comparable anti-obesity agents Jun 27, 2023
<乌鸦传媒>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Loss Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023
